GLOBAL WORKSHOPS

Locum International Group - Drug Development publishers of the renown, peer reviewed international journal and 24 volume handbook series on innovative and generic drug development have initiated drug development workshops in the world's leading research centers

GLIMER I & II STUDY - Multiple Sclerosis Global Initiative.
Locum International Group, LocumEuro and Locum LocumInternational LLC (US) as well as IAGIM researchers have undertaken a 5 - 8 year global initiative in the study of all five types of Multiple Sclerosis covering diverse fields of thyroid lymhocyte T-cell selection, Virology (EBV, HH6), Blood CNC Barrier penetration, Protein folding errors, (Oligodendrites), Chronic CNS inflammation, Autoimmune scaring and lesions, among many others in terms of MS Epidemiology, Etiology and Epigenetics.